INVA Innoviva PE ratio, current and historical analysis
As of Mar 21, 2025, the Innoviva stock's PE ratio is 46.68. This takes into account the latest EPS of $0.37 and stock price of $17.27. The PE ratio has increased by 137% from its last 4 quarters average of 19.7.
INVA PE ratio history
The PE ratio of Innoviva has averaged 11.51 over the last nine years. The current price-to-earnings ratio of 46.68 is in line with the historical average. Analyzing the last nine years, INVA's PE ratio reached its highest point in the Jun 2016 quarter at 61.94, when the price was $10.53 and the EPS was $0.17. The lowest point was recorded in the Sep 2022 quarter, when it reached 2.68 with a price of $11.61 and an EPS of $4.33.
Innoviva PE ratio by year
Maximum annual increase: 704.29% in 2024
Maximum annual decrease: -60.79% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 46.89 | 704.29% | $17.35 | $0.37 |
| 2023 | 5.83 | 34.95% | $16.04 | $2.75 |
| 2022 | 4.32 | -18.8% | $13.25 | $3.07 |
| 2021 | 5.32 | -5.17% | $17.25 | $3.24 |
| 2020 | 5.61 | -38.62% | $12.39 | $2.21 |
| 2019 | 9.14 | 105.39% | $14.16 | $1.55 |
| 2018 | 4.45 | -60.79% | $17.45 | $3.92 |
| 2017 | 11.35 | -42.71% | $14.19 | $1.25 |
| 2016 | 19.81 | N/A | $10.7 | $0.54 |
| 2015 | N/A | N/A | $10.54 | -$0.16 |
| 2014 | N/A | N/A | $14.15 | -$1.5 |
| 2013 | N/A | N/A | $28.73 | -$1.67 |
| 2012 | N/A | N/A | $17.92 | -$0.2 |
| 2011 | N/A | N/A | $17.81 | -$1.41 |
| 2010 | N/A | N/A | $20.2 | -$1.16 |
Innoviva PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 46.89 | 145.24% | $17.35 | $0.37 |
| Sep 2024 | 19.12 | 162.28% | $19.31 | $1.01 |
| Jun 2024 | 7.29 | 35% | $16.4 | $2.25 |
| Mar 2024 | 5.4 | -7.38% | $15.24 | $2.82 |
| Dec 2023 | 5.83 | -63.65% | $16.04 | $2.75 |
| Sep 2023 | 16.04 | 323.22% | $12.99 | $0.81 |
| Jun 2023 | 3.79 | 12.8% | $12.73 | $3.36 |
| Mar 2023 | 3.36 | -22.22% | $11.25 | $3.35 |
| Dec 2022 | 4.32 | 61.19% | $13.25 | $3.07 |
| Sep 2022 | 2.68 | -71.67% | $11.61 | $4.33 |
| Jun 2022 | 9.46 | 25.13% | $14.76 | $1.56 |
| Mar 2022 | 7.56 | 42.11% | $19.35 | $2.56 |
| Dec 2021 | 5.32 | 11.76% | $17.25 | $3.24 |
| Sep 2021 | 4.76 | -2.46% | $16.71 | $3.51 |
| Jun 2021 | 4.88 | 2.09% | $13.41 | $2.75 |
INVA average PE ratio chart
The current PE ratio of INVA is above its 3, 5 and 10-year averages.
INVA PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| INVA Innoviva Inc | 46.68 | $1.08B |
| OPTN OptiNose Inc | N/A | $92.01M |
| OPK Opko Health Inc | N/A | $1.21B |
| ORGO Organogenesis Holdings Inc | N/A | $618.92M |
Frequently asked questions
What is Innoviva's PE ratio?
As of Mar 21, 2025, INVA stock has a price to earnings ratio of 46.68.
What is the 3-year average PE ratio for Innoviva (INVA)?
The 3-year average PE ratio for INVA stock is 10.98.
What is the 5-year average PE ratio for Innoviva (INVA)?
The 5-year average PE ratio for INVA stock is 8.73.
What is the highest PE ratio for INVA?
Over the last nine years, the quarterly PE ratio reached its highest level at 61.94 in the Jun 2016 quarter.
How does the current PE ratio for INVA compare to its historical average?
INVA's price to earnings ratio is currently 306% above its 9-year historical average.
How is INVA's PE ratio calculated (Innoviva PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Mar 21, 2025), Innoviva's share price is $17.27. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $0.37. Therefore, Innoviva's price to earnings ratio for today is 46.68. PE RATIO(46.68) = STOCK PRICE($17.27) / TTM EPS($0.37)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.